ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,367
Screening encounters
3,897
Diagnostic referrals
744
Outstanding pathways
280

Screening pathway

  1. Screening3,897Encounters
  2. Positive finding1,352Documented findings
  3. Referral744Diagnostic referrals
  4. Follow-up872Diagnostic visits
  5. Outcome464Resolved pathways

Stage totals use different units. Pending pathways: 280. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 2792 · EXP-2792Synthetic · Site A

Full participant history through 2026-08-24, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-05
  4. · Diagnostic referral · EXP-2792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-11-15
  11. · Follow-up disposition · Resolved · EXP-2792-T-R
  12. · Screening · HPV DNA · Repeat · Prior VIA positive
  13. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3367 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2658 · Expanded synthetic participant 2658Site E — Resource-Constrained Navigation Programme
EXP-2659 · Expanded synthetic participant 2659Site E — Resource-Constrained Navigation Programme
EXP-2661 · Expanded synthetic participant 2661Site C — Rural Outreach Programme
EXP-2662 · Expanded synthetic participant 2662Site C — Rural Outreach Programme
EXP-2663 · Expanded synthetic participant 2663Site B — Peri-Urban Access Programme
EXP-2665 · Expanded synthetic participant 2665Site E — Resource-Constrained Navigation Programme
EXP-2666 · Expanded synthetic participant 2666Site B — Peri-Urban Access Programme
EXP-2668 · Expanded synthetic participant 2668Site A — Urban Referral Hub
EXP-2672 · Expanded synthetic participant 2672Site C — Rural Outreach Programme
EXP-2674 · Expanded synthetic participant 2674Site B — Peri-Urban Access Programme
EXP-2675 · Expanded synthetic participant 2675Site D — Community Engagement Programme
EXP-2677 · Expanded synthetic participant 2677Site A — Urban Referral Hub
EXP-2678 · Expanded synthetic participant 2678Site A — Urban Referral Hub
EXP-2680 · Expanded synthetic participant 2680Site E — Resource-Constrained Navigation Programme
EXP-2681 · Expanded synthetic participant 2681Site C — Rural Outreach Programme
EXP-2682 · Expanded synthetic participant 2682Site B — Peri-Urban Access Programme
EXP-2685 · Expanded synthetic participant 2685Site B — Peri-Urban Access Programme
EXP-2686 · Expanded synthetic participant 2686Site D — Community Engagement Programme
EXP-2687 · Expanded synthetic participant 2687Site B — Peri-Urban Access Programme
EXP-2688 · Expanded synthetic participant 2688Site B — Peri-Urban Access Programme
EXP-2690 · Expanded synthetic participant 2690Site A — Urban Referral Hub
EXP-2691 · Expanded synthetic participant 2691Site D — Community Engagement Programme
EXP-2692 · Expanded synthetic participant 2692Site E — Resource-Constrained Navigation Programme
EXP-2694 · Expanded synthetic participant 2694Site A — Urban Referral Hub
EXP-2695 · Expanded synthetic participant 2695Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1540
HPV DNA
1801
Cytology
556

Navigation activity

Barrier documented
641
Contact attempt
1089
Navigation intervention
274
Diagnostic booking
916
Diagnostic visit
872

Documented barriers

Contact difficulty
213
Transport difficulty
201
Appointment coordination
227

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.